CANNAPHARMARX, INC. (CPMD) SEC Filing 10-Q Quarterly report for the period ending Saturday, June 30, 2018

PDFPDF Microsoft WordWord Microsoft ExcelExcel SubscribeRSS E-mailEmail Smartphone and TabletMobile last10k.com/sec-filings/cpmd/0001683168-18-002749.htm
Document and Entity Information - shares
6 Months Ended
Jun. 30, 2018
Sep. 13, 2018
Document And Entity Information  
Entity Registrant NameCannaPharmaRX, Inc. 
Entity Central Index Key0001081938 
Document Type10-Q 
Document Period End DateJun. 30, 2018 
Amendment Flagfalse 
Current Fiscal Year End Date--12-31 
Is Entity a Well-known Seasoned Issuer?No 
Is Entity a Voluntary Filer?No 
Is Entity's Reporting Status Current?No 
Entity Filer CategorySmaller Reporting Company 
Entity Common Stock, Shares Outstanding 17,960,741
Document Fiscal Period FocusQ2 
Document Fiscal Year Focus2018 

 Please wait while we load the requested 10-Q Quarterly Report. If it does not load, please click the link below:

 https://www.last10k.com/sec-filings/report/1081938/000168316818002749/cannapharmarx_10q-063018.htm

Companies may provide additional information to their SEC Filings as exhibits. Click a link below to view an exhibit that was filed with this report:

Exhibit 31.1 - CERTIFICATION

 Please wait while we load the requested exhibit. If it does not load, please click the link below:

 https://www.last10k.com/sec-filings/report/1081938/000168316818002749/cannapharmarx_10q-ex3101.htm
Exhibit 31.2 - CERTIFICATION

 Please wait while we load the requested exhibit. If it does not load, please click the link below:

 https://www.last10k.com/sec-filings/report/1081938/000168316818002749/cannapharmarx_10q-ex3102.htm
Exhibit 32 - CERTIFICATION

 Please wait while we load the requested exhibit. If it does not load, please click the link below:

 https://www.last10k.com/sec-filings/report/1081938/000168316818002749/cannapharmarx_10q-ex32.htm
  • Form Type: Quarterly
  • Number of times amended: 0
  • Accession Number: 0001683168-18-002749
  • Submitted to the SEC: Friday, September 14, 2018 8:07:03 AM EST
  • Accepted by the SEC: Friday, September 14, 2018
  • Period ending: June 2018
  • Industry: Pharmaceutical Preparations